![]() | NEJM Interview: Joseph Ross on the newly implemented Cell and Gene Therapy Access Model. Süre: 8:19 | Boyut: 19.04 MB |
![]() | NEJM Interview: Daniel Aaron on a Supreme Court case about e-cigarettes that could have implicati... Süre: 9:22 | Boyut: 21.44 MB |
![]() | Antithrombosis for Atrial Fibrillation and Coronary Artery Disease | NEJM Süre: 2:39 | Boyut: 6.07 MB |
![]() | Dr. Glaucomflecken Explains: Tenecteplase for Ischemic Stroke at 4.5 to 24 Hours Süre: 1:40 | Boyut: 3.81 MB |
![]() | Dr. Glaucomflecken Explains: Iodine or Chlorhexidine for Surgical Prep of an Extremity Fracture? Süre: 1:23 | Boyut: 3.17 MB |
![]() | NEJM at ESC — Edoxaban Antithrombotic Therapy for Atrial Fibrillation and Stable Coronary Artery ... Süre: 4:08 | Boyut: 9.46 MB |